Structure

Physi-Chem Properties

Molecular Weight:  398.28
Volume:  433.931
LogP:  4.339
LogD:  3.834
LogS:  -4.85
# Rotatable Bonds:  1
TPSA:  57.53
# H-Bond Aceptor:  3
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.665
Synthetic Accessibility Score:  5.048
Fsp3:  0.808
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.796
MDCK Permeability:  2.1950623704469763e-05
Pgp-inhibitor:  0.982
Pgp-substrate:  0.054
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.917
30% Bioavailability (F30%):  0.952

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.543
Plasma Protein Binding (PPB):  90.64655303955078%
Volume Distribution (VD):  0.687
Pgp-substrate:  6.19228982925415%

ADMET: Metabolism

CYP1A2-inhibitor:  0.041
CYP1A2-substrate:  0.109
CYP2C19-inhibitor:  0.047
CYP2C19-substrate:  0.699
CYP2C9-inhibitor:  0.107
CYP2C9-substrate:  0.061
CYP2D6-inhibitor:  0.067
CYP2D6-substrate:  0.153
CYP3A4-inhibitor:  0.842
CYP3A4-substrate:  0.336

ADMET: Excretion

Clearance (CL):  9.706
Half-life (T1/2):  0.134

ADMET: Toxicity

hERG Blockers:  0.502
Human Hepatotoxicity (H-HT):  0.472
Drug-inuced Liver Injury (DILI):  0.047
AMES Toxicity:  0.015
Rat Oral Acute Toxicity:  0.883
Maximum Recommended Daily Dose:  0.972
Skin Sensitization:  0.943
Carcinogencity:  0.486
Eye Corrosion:  0.008
Eye Irritation:  0.064
Respiratory Toxicity:  0.98

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471207

Natural Product ID:  NPC471207
Common Name*:   Rel-12Beta,22-Dihydroxy-24-Oxo-24-Homoscalara-16,25(26)-Diene
IUPAC Name:   (5aS,5bR,7aS,11aR,11bS,13R,13aS,13bR)-13-hydroxy-11a-(hydroxymethyl)-5b,8,8,13a-tetramethyl-5,5a,6,7,7a,9,10,11,11b,12,13,13b-dodecahydrocyclopenta[a]chrysen-3-one
Synonyms:  
Standard InCHIKey:  SCQWNYQIOKUMKH-AJSCXSSXSA-N
Standard InCHI:  InChI=1S/C26H38O3/c1-23(2)11-5-12-26(15-27)19(23)10-13-24(3)20-9-6-16-17(7-8-18(16)28)25(20,4)22(29)14-21(24)26/h6-8,17,19-22,27,29H,5,9-15H2,1-4H3/t17-,19-,20-,21-,22+,24-,25+,26+/m0/s1
SMILES:  OC[C@@]12CCCC([C@@H]2CC[C@@]2([C@@H]1C[C@@H](O)[C@]1([C@H]2CC=C2[C@@H]1C=CC2=O)C)C)(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2387626
PubChem CID:   71658747
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001552] Sesterterpenoids
          • [CHEMONTID:0002883] Scalarane sesterterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32746 madagascan sponges Species n.a. n.a. n.a. n.a. n.a. PMID[23623678]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1383 Cell Line A2058 Homo sapiens IC50 = 4170.0 nM PMID[519186]
NPT179 Cell Line A2780 Homo sapiens IC50 = 4500.0 nM PMID[519186]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 5280.0 nM PMID[519186]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471207 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9213 High Similarity NPC85173
0.913 High Similarity NPC469545
0.913 High Similarity NPC5532
0.913 High Similarity NPC61369
0.9111 High Similarity NPC272746
0.8989 High Similarity NPC474925
0.8791 High Similarity NPC126993
0.8778 High Similarity NPC328539
0.8778 High Similarity NPC158778
0.8778 High Similarity NPC472802
0.8778 High Similarity NPC206060
0.8764 High Similarity NPC158393
0.8737 High Similarity NPC114274
0.8696 High Similarity NPC131872
0.8681 High Similarity NPC472973
0.8681 High Similarity NPC69627
0.8681 High Similarity NPC275740
0.8681 High Similarity NPC186688
0.8681 High Similarity NPC119416
0.8681 High Similarity NPC86319
0.8667 High Similarity NPC298904
0.8667 High Similarity NPC93778
0.8652 High Similarity NPC470574
0.8652 High Similarity NPC133954
0.8632 High Similarity NPC190554
0.8632 High Similarity NPC108078
0.8617 High Similarity NPC473170
0.8617 High Similarity NPC139570
0.8571 High Similarity NPC282233
0.8571 High Similarity NPC95585
0.8571 High Similarity NPC193360
0.8571 High Similarity NPC131470
0.8571 High Similarity NPC143767
0.8571 High Similarity NPC474677
0.8556 High Similarity NPC213412
0.8556 High Similarity NPC475862
0.8556 High Similarity NPC471737
0.8556 High Similarity NPC74363
0.8556 High Similarity NPC472985
0.8556 High Similarity NPC472986
0.8542 High Similarity NPC103051
0.8526 High Similarity NPC473158
0.8511 High Similarity NPC103527
0.8511 High Similarity NPC23170
0.8511 High Similarity NPC245972
0.8511 High Similarity NPC111015
0.8511 High Similarity NPC196485
0.8495 Intermediate Similarity NPC4036
0.8495 Intermediate Similarity NPC185936
0.8495 Intermediate Similarity NPC168027
0.8495 Intermediate Similarity NPC472978
0.8495 Intermediate Similarity NPC233455
0.8495 Intermediate Similarity NPC472975
0.8495 Intermediate Similarity NPC158030
0.8495 Intermediate Similarity NPC145067
0.8495 Intermediate Similarity NPC65120
0.8462 Intermediate Similarity NPC141292
0.8462 Intermediate Similarity NPC475740
0.8462 Intermediate Similarity NPC73064
0.8462 Intermediate Similarity NPC58063
0.8462 Intermediate Similarity NPC153604
0.8454 Intermediate Similarity NPC15390
0.8438 Intermediate Similarity NPC473456
0.8427 Intermediate Similarity NPC64600
0.8421 Intermediate Similarity NPC473240
0.8421 Intermediate Similarity NPC271195
0.8421 Intermediate Similarity NPC259286
0.8409 Intermediate Similarity NPC473217
0.8404 Intermediate Similarity NPC134826
0.8404 Intermediate Similarity NPC214756
0.8404 Intermediate Similarity NPC295643
0.8404 Intermediate Similarity NPC272075
0.8404 Intermediate Similarity NPC69454
0.8387 Intermediate Similarity NPC191684
0.8387 Intermediate Similarity NPC183283
0.837 Intermediate Similarity NPC471722
0.837 Intermediate Similarity NPC310752
0.837 Intermediate Similarity NPC292491
0.8352 Intermediate Similarity NPC474732
0.8352 Intermediate Similarity NPC145879
0.8352 Intermediate Similarity NPC31564
0.8352 Intermediate Similarity NPC477579
0.8352 Intermediate Similarity NPC72133
0.8352 Intermediate Similarity NPC474733
0.8352 Intermediate Similarity NPC235341
0.8352 Intermediate Similarity NPC95594
0.8352 Intermediate Similarity NPC474778
0.8333 Intermediate Similarity NPC214043
0.8333 Intermediate Similarity NPC476318
0.8333 Intermediate Similarity NPC227132
0.8333 Intermediate Similarity NPC471039
0.8333 Intermediate Similarity NPC146683
0.8333 Intermediate Similarity NPC249954
0.8333 Intermediate Similarity NPC476327
0.8333 Intermediate Similarity NPC180834
0.8333 Intermediate Similarity NPC85774
0.8317 Intermediate Similarity NPC110496
0.8316 Intermediate Similarity NPC472977
0.8316 Intermediate Similarity NPC474529
0.8316 Intermediate Similarity NPC473172
0.8316 Intermediate Similarity NPC472976
0.8316 Intermediate Similarity NPC209662
0.8315 Intermediate Similarity NPC48362
0.8298 Intermediate Similarity NPC63748
0.8298 Intermediate Similarity NPC475806
0.8298 Intermediate Similarity NPC233116
0.8295 Intermediate Similarity NPC2482
0.8295 Intermediate Similarity NPC476809
0.828 Intermediate Similarity NPC184663
0.828 Intermediate Similarity NPC1015
0.828 Intermediate Similarity NPC473999
0.828 Intermediate Similarity NPC309603
0.828 Intermediate Similarity NPC31985
0.8265 Intermediate Similarity NPC471041
0.8265 Intermediate Similarity NPC144956
0.8261 Intermediate Similarity NPC130577
0.8261 Intermediate Similarity NPC68160
0.8261 Intermediate Similarity NPC18064
0.8261 Intermediate Similarity NPC98442
0.8261 Intermediate Similarity NPC171203
0.8261 Intermediate Similarity NPC142415
0.8261 Intermediate Similarity NPC51700
0.8261 Intermediate Similarity NPC307426
0.8261 Intermediate Similarity NPC88716
0.8261 Intermediate Similarity NPC259009
0.8261 Intermediate Similarity NPC102683
0.8261 Intermediate Similarity NPC242468
0.8261 Intermediate Similarity NPC293564
0.8252 Intermediate Similarity NPC197428
0.8247 Intermediate Similarity NPC189880
0.8242 Intermediate Similarity NPC190704
0.8242 Intermediate Similarity NPC469948
0.8242 Intermediate Similarity NPC471034
0.8242 Intermediate Similarity NPC476426
0.8235 Intermediate Similarity NPC275539
0.8235 Intermediate Similarity NPC189075
0.8229 Intermediate Similarity NPC148523
0.8229 Intermediate Similarity NPC280725
0.8229 Intermediate Similarity NPC139459
0.8222 Intermediate Similarity NPC118800
0.8222 Intermediate Similarity NPC307258
0.8211 Intermediate Similarity NPC79117
0.8211 Intermediate Similarity NPC475255
0.8211 Intermediate Similarity NPC12722
0.8211 Intermediate Similarity NPC477855
0.8202 Intermediate Similarity NPC3915
0.82 Intermediate Similarity NPC312900
0.82 Intermediate Similarity NPC264048
0.82 Intermediate Similarity NPC478057
0.82 Intermediate Similarity NPC95899
0.8191 Intermediate Similarity NPC48010
0.8191 Intermediate Similarity NPC80401
0.8191 Intermediate Similarity NPC291028
0.8191 Intermediate Similarity NPC328141
0.8172 Intermediate Similarity NPC246708
0.8172 Intermediate Similarity NPC40552
0.8172 Intermediate Similarity NPC470629
0.8172 Intermediate Similarity NPC471724
0.8172 Intermediate Similarity NPC290690
0.8172 Intermediate Similarity NPC473242
0.8172 Intermediate Similarity NPC182797
0.8172 Intermediate Similarity NPC230387
0.8172 Intermediate Similarity NPC52169
0.8172 Intermediate Similarity NPC53911
0.8172 Intermediate Similarity NPC17733
0.8172 Intermediate Similarity NPC474512
0.8172 Intermediate Similarity NPC181225
0.8163 Intermediate Similarity NPC58942
0.8163 Intermediate Similarity NPC194196
0.8163 Intermediate Similarity NPC260149
0.8161 Intermediate Similarity NPC472746
0.8161 Intermediate Similarity NPC197659
0.8152 Intermediate Similarity NPC222613
0.8152 Intermediate Similarity NPC118648
0.8152 Intermediate Similarity NPC72638
0.8152 Intermediate Similarity NPC327115
0.8152 Intermediate Similarity NPC94666
0.8152 Intermediate Similarity NPC475022
0.8152 Intermediate Similarity NPC194417
0.8144 Intermediate Similarity NPC98874
0.8144 Intermediate Similarity NPC192428
0.8144 Intermediate Similarity NPC472806
0.8144 Intermediate Similarity NPC473164
0.8144 Intermediate Similarity NPC167193
0.8132 Intermediate Similarity NPC473246
0.8132 Intermediate Similarity NPC251170
0.8132 Intermediate Similarity NPC33913
0.8132 Intermediate Similarity NPC59453
0.8132 Intermediate Similarity NPC161423
0.8132 Intermediate Similarity NPC472265
0.8132 Intermediate Similarity NPC227064
0.8132 Intermediate Similarity NPC221758
0.8132 Intermediate Similarity NPC470812
0.8132 Intermediate Similarity NPC476412
0.8132 Intermediate Similarity NPC329043
0.8132 Intermediate Similarity NPC321187
0.8132 Intermediate Similarity NPC58841
0.8125 Intermediate Similarity NPC74751
0.8125 Intermediate Similarity NPC8993
0.8125 Intermediate Similarity NPC471040

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471207 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9111 High Similarity NPD6079 Approved
0.8889 High Similarity NPD5328 Approved
0.8556 High Similarity NPD3618 Phase 1
0.8526 High Similarity NPD5221 Approved
0.8526 High Similarity NPD5220 Clinical (unspecified phase)
0.8526 High Similarity NPD5222 Approved
0.8495 Intermediate Similarity NPD7515 Phase 2
0.8438 Intermediate Similarity NPD5173 Approved
0.8265 Intermediate Similarity NPD4696 Approved
0.8265 Intermediate Similarity NPD5286 Approved
0.8265 Intermediate Similarity NPD5285 Approved
0.8182 Intermediate Similarity NPD5223 Approved
0.8144 Intermediate Similarity NPD4697 Phase 3
0.8132 Intermediate Similarity NPD3665 Phase 1
0.8132 Intermediate Similarity NPD4786 Approved
0.8132 Intermediate Similarity NPD3133 Approved
0.8132 Intermediate Similarity NPD3666 Approved
0.8125 Intermediate Similarity NPD7748 Approved
0.8111 Intermediate Similarity NPD3667 Approved
0.81 Intermediate Similarity NPD4633 Approved
0.81 Intermediate Similarity NPD5225 Approved
0.81 Intermediate Similarity NPD5224 Approved
0.81 Intermediate Similarity NPD5226 Approved
0.81 Intermediate Similarity NPD5211 Phase 2
0.8061 Intermediate Similarity NPD4755 Approved
0.8021 Intermediate Similarity NPD4202 Approved
0.802 Intermediate Similarity NPD5175 Approved
0.802 Intermediate Similarity NPD5174 Approved
0.7941 Intermediate Similarity NPD5141 Approved
0.7905 Intermediate Similarity NPD4634 Approved
0.79 Intermediate Similarity NPD4700 Approved
0.7885 Intermediate Similarity NPD6899 Approved
0.7885 Intermediate Similarity NPD6881 Approved
0.7879 Intermediate Similarity NPD7902 Approved
0.7872 Intermediate Similarity NPD3573 Approved
0.7788 Intermediate Similarity NPD5697 Approved
0.7736 Intermediate Similarity NPD7102 Approved
0.7736 Intermediate Similarity NPD6883 Approved
0.7736 Intermediate Similarity NPD7290 Approved
0.7714 Intermediate Similarity NPD5168 Approved
0.7714 Intermediate Similarity NPD4730 Approved
0.7714 Intermediate Similarity NPD4729 Approved
0.7714 Intermediate Similarity NPD6011 Approved
0.7692 Intermediate Similarity NPD6675 Approved
0.7692 Intermediate Similarity NPD6402 Approved
0.7692 Intermediate Similarity NPD7128 Approved
0.7692 Intermediate Similarity NPD5739 Approved
0.7685 Intermediate Similarity NPD4632 Approved
0.767 Intermediate Similarity NPD4754 Approved
0.7664 Intermediate Similarity NPD6847 Approved
0.7664 Intermediate Similarity NPD6649 Approved
0.7664 Intermediate Similarity NPD6617 Approved
0.7664 Intermediate Similarity NPD8130 Phase 1
0.7664 Intermediate Similarity NPD6650 Approved
0.7664 Intermediate Similarity NPD6869 Approved
0.766 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7642 Intermediate Similarity NPD6014 Approved
0.7642 Intermediate Similarity NPD6012 Approved
0.7642 Intermediate Similarity NPD6013 Approved
0.7624 Intermediate Similarity NPD7638 Approved
0.7604 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD6882 Approved
0.7593 Intermediate Similarity NPD8297 Approved
0.7582 Intermediate Similarity NPD7645 Phase 2
0.7579 Intermediate Similarity NPD4623 Approved
0.7579 Intermediate Similarity NPD5279 Phase 3
0.7579 Intermediate Similarity NPD4519 Discontinued
0.7579 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD7900 Approved
0.757 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.757 Intermediate Similarity NPD5135 Approved
0.757 Intermediate Similarity NPD5169 Approved
0.757 Intermediate Similarity NPD5251 Approved
0.757 Intermediate Similarity NPD5250 Approved
0.757 Intermediate Similarity NPD5247 Approved
0.757 Intermediate Similarity NPD5248 Approved
0.757 Intermediate Similarity NPD5249 Phase 3
0.7549 Intermediate Similarity NPD7640 Approved
0.7549 Intermediate Similarity NPD7639 Approved
0.7547 Intermediate Similarity NPD5128 Approved
0.7547 Intermediate Similarity NPD7320 Approved
0.7528 Intermediate Similarity NPD3703 Phase 2
0.7527 Intermediate Similarity NPD4223 Phase 3
0.7527 Intermediate Similarity NPD4221 Approved
0.7526 Intermediate Similarity NPD4753 Phase 2
0.7524 Intermediate Similarity NPD4767 Approved
0.7524 Intermediate Similarity NPD4768 Approved
0.75 Intermediate Similarity NPD5215 Approved
0.75 Intermediate Similarity NPD5127 Approved
0.75 Intermediate Similarity NPD5217 Approved
0.75 Intermediate Similarity NPD4629 Approved
0.75 Intermediate Similarity NPD5216 Approved
0.75 Intermediate Similarity NPD4695 Discontinued
0.75 Intermediate Similarity NPD5210 Approved
0.7477 Intermediate Similarity NPD6373 Approved
0.7477 Intermediate Similarity NPD6009 Approved
0.7477 Intermediate Similarity NPD6372 Approved
0.7474 Intermediate Similarity NPD5329 Approved
0.7453 Intermediate Similarity NPD5701 Approved
0.7447 Intermediate Similarity NPD4788 Approved
0.7434 Intermediate Similarity NPD6054 Approved
0.7396 Intermediate Similarity NPD6684 Approved
0.7396 Intermediate Similarity NPD5330 Approved
0.7396 Intermediate Similarity NPD7521 Approved
0.7396 Intermediate Similarity NPD5690 Phase 2
0.7396 Intermediate Similarity NPD7146 Approved
0.7396 Intermediate Similarity NPD6409 Approved
0.7396 Intermediate Similarity NPD7334 Approved
0.7387 Intermediate Similarity NPD6868 Approved
0.7368 Intermediate Similarity NPD3668 Phase 3
0.7368 Intermediate Similarity NPD4197 Approved
0.7339 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD7525 Registered
0.7304 Intermediate Similarity NPD6370 Approved
0.73 Intermediate Similarity NPD6399 Phase 3
0.7297 Intermediate Similarity NPD5167 Approved
0.729 Intermediate Similarity NPD6412 Phase 2
0.7288 Intermediate Similarity NPD7736 Approved
0.7283 Intermediate Similarity NPD3617 Approved
0.7281 Intermediate Similarity NPD6319 Approved
0.7257 Intermediate Similarity NPD6335 Approved
0.7245 Intermediate Similarity NPD6903 Approved
0.7241 Intermediate Similarity NPD7604 Phase 2
0.7217 Intermediate Similarity NPD6016 Approved
0.7217 Intermediate Similarity NPD6015 Approved
0.7217 Intermediate Similarity NPD5983 Phase 2
0.7216 Intermediate Similarity NPD4690 Approved
0.7216 Intermediate Similarity NPD4689 Approved
0.7216 Intermediate Similarity NPD4688 Approved
0.7216 Intermediate Similarity NPD4138 Approved
0.7216 Intermediate Similarity NPD4693 Phase 3
0.7216 Intermediate Similarity NPD5205 Approved
0.7204 Intermediate Similarity NPD4195 Approved
0.7196 Intermediate Similarity NPD6008 Approved
0.7193 Intermediate Similarity NPD7101 Approved
0.7193 Intermediate Similarity NPD7100 Approved
0.7184 Intermediate Similarity NPD6083 Phase 2
0.7184 Intermediate Similarity NPD6084 Phase 2
0.7179 Intermediate Similarity NPD7492 Approved
0.7172 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD6317 Approved
0.7168 Intermediate Similarity NPD7115 Discovery
0.7155 Intermediate Similarity NPD5988 Approved
0.7143 Intermediate Similarity NPD6942 Approved
0.7143 Intermediate Similarity NPD7339 Approved
0.713 Intermediate Similarity NPD6059 Approved
0.7119 Intermediate Similarity NPD6336 Discontinued
0.7119 Intermediate Similarity NPD6616 Approved
0.7115 Intermediate Similarity NPD5290 Discontinued
0.7105 Intermediate Similarity NPD6313 Approved
0.7105 Intermediate Similarity NPD6314 Approved
0.7094 Intermediate Similarity NPD8328 Phase 3
0.7087 Intermediate Similarity NPD7614 Phase 1
0.708 Intermediate Similarity NPD6274 Approved
0.7079 Intermediate Similarity NPD4691 Approved
0.7071 Intermediate Similarity NPD6672 Approved
0.7071 Intermediate Similarity NPD5737 Approved
0.7065 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7078 Approved
0.7041 Intermediate Similarity NPD5280 Approved
0.7041 Intermediate Similarity NPD4694 Approved
0.7033 Intermediate Similarity NPD4058 Approved
0.703 Intermediate Similarity NPD8035 Phase 2
0.703 Intermediate Similarity NPD8034 Phase 2
0.703 Intermediate Similarity NPD6411 Approved
0.7 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.6966 Remote Similarity NPD3699 Clinical (unspecified phase)
0.6966 Remote Similarity NPD4137 Phase 3
0.6966 Remote Similarity NPD3700 Clinical (unspecified phase)
0.6947 Remote Similarity NPD8259 Clinical (unspecified phase)
0.6939 Remote Similarity NPD1694 Approved
0.6939 Remote Similarity NPD1696 Phase 3
0.6923 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6916 Remote Similarity NPD7632 Discontinued
0.6915 Remote Similarity NPD6115 Approved
0.6915 Remote Similarity NPD6114 Approved
0.6915 Remote Similarity NPD6697 Approved
0.6915 Remote Similarity NPD6118 Approved
0.6889 Remote Similarity NPD4747 Approved
0.6863 Remote Similarity NPD5281 Approved
0.6863 Remote Similarity NPD5284 Approved
0.6833 Remote Similarity NPD7507 Approved
0.6832 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6832 Remote Similarity NPD6101 Approved
0.6827 Remote Similarity NPD5695 Phase 3
0.6827 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6818 Remote Similarity NPD7331 Phase 2
0.6796 Remote Similarity NPD5779 Approved
0.6796 Remote Similarity NPD5778 Approved
0.6792 Remote Similarity NPD5696 Approved
0.678 Remote Similarity NPD6909 Approved
0.678 Remote Similarity NPD6908 Approved
0.6777 Remote Similarity NPD8293 Discontinued
0.6762 Remote Similarity NPD7732 Phase 3
0.6757 Remote Similarity NPD6686 Approved
0.6721 Remote Similarity NPD6033 Approved
0.6705 Remote Similarity NPD7341 Phase 2
0.6703 Remote Similarity NPD4244 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data